UPDATE: KeyBanc Capital Markets Initiates Coverage on Envision Healthcare on Positive Outlook

In a report published Wednesday, KeyBanc Capital Markets analyst Jason Gurda initiated coverage on Envision Healthcare (NYSE: EVHC ) with a Buy rating and $40.00 price target. In the report, KeyBanc Capital Markets noted, “Expansion beyond emergency department (ED) staffing to include anesthesiology, hospitalists and other specialists is driving accelerated